Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group

Affiliations

• ¹ Division of Pediatric Hematology-Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center, Freiburg, Germany.
• ² Division of Pediatric Hematology-Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center, Freiburg, Germany German Cancer Consortium (DKTK), Heidelberg, Germany.
• ³ St. Anna Children's Hospital and Children's Cancer Research Institute, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
• ⁴ Department of Pediatrics, Aarhus University Hospital, Skejby, Denmark.
• ⁵ Erasmus Medical Centre, Rotterdam, The Netherlands.
• ⁶ Department of Pediatric Hematology-Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Bambino Gesù, Rome, Italy University of Pavia, Pavia, Italy.
• ⁷ Pediatric Oncology and Hematology, University of Bologna, Bologna, Italy.
• ⁸ Department of Hematology and Oncology, University Children's Hospital, Zurich, Switzerland.
• ⁹ Olgahospital, Pediatrics 5 (Oncology, Hematology, Immunology, Rheumatology, Gastroenterology, and General Pediatrics), Klinikum Stuttgart, Stuttgart, Germany.
• ¹⁰ Department of Hematology and Oncology, Pediatric Hospital Prof Dr Juan P. Garrahan, Buenos Aires, Argentina.
• ¹¹ Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany.
• ¹² Department of Pediatric Hematology, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital of the Ministry of Health, Ankara, Turkey.
• ¹³ Division of Pediatric Hematology and Oncology, University Children's Hospital, Dresden, Germany.
• ¹⁴ University Children's Hospital, Ulm, Germany.